Your browser doesn't support javascript.
loading
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment.
Lanteri, Paola; Meola, Irene; Canosa, Antonio; De Marco, Giovanni; Lomartire, Annarosa; Rinaudo, Maria Teresa; Albamonte, Emilio; Sansone, Valeria Ada; Lunetta, Christian; Manera, Umberto; Vasta, Rosario; Moglia, Cristina; Calvo, Andrea; Origone, Paola; Chiò, Adriano; Mandich, Paola.
Afiliación
  • Lanteri P; Neurophysiopathology Centre, Department of Diagnostics and Applied Technology, Fondazione IRCCS, Istituto Neurologico "C. Besta", Milan, Italy.
  • Meola I; Child Neurology Unit, Cesare Arrigo Children's Hospital, Alessandria, Italy.
  • Canosa A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy; Neurology 1, ALS Center, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • De Marco G; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
  • Lomartire A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
  • Rinaudo MT; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy.
  • Albamonte E; The NEMO Clinical Center (NEuroMuscular Onmicenter), Milan, Italy.
  • Sansone VA; The NEMO Clinical Center (NEuroMuscular Onmicenter), Milan, Italy; Neurorehabilitation Unit, University of Milan, Milan, Italy.
  • Lunetta C; The NEMO Clinical Center (NEuroMuscular Onmicenter), Milan, Italy.
  • Manera U; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy; Neurology 1, ALS Center, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Vasta R; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy; Neurology 1, ALS Center, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Moglia C; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy; Neurology 1, ALS Center, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Calvo A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy; Neurology 1, ALS Center, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
  • Origone P; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI) University of Genoa and IRCCS Policlinico San Martino, Genoa, Italy; IRCCS Policlinico San Martino, Genoa, Italy.
  • Chiò A; 'Rita Levi Montalcini' Department of Neuroscience, University of Turin, Turin, Italy; Neurology 1, ALS Center, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; Institute of Cognitive Sciences and Technologies, C.N.R, Rome, Italy. Electronic address: adria
  • Mandich P; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI) University of Genoa and IRCCS Policlinico San Martino, Genoa, Italy; IRCCS Policlinico San Martino, Genoa, Italy.
Neurobiol Aging ; 103: 130.e1-130.e7, 2021 07.
Article en En | MEDLINE | ID: mdl-33637330
ABSTRACT
We report a case of childhood-onset ALS with a FUS gene mutation presenting cognitive impairment and a rapid clinical progression. The patient, an 11-year-old girl, presented with right distal upper limb weakness and mild intellectual disability at the Griffith Mental Development Scales. The disease rapidly worsened and the patient became tetraplegic and bed-ridden 2 years after symptom onset. A c.1509_1510delAG mutation in exon 14 of the FUS gene was detected, resulting in a predicted truncated protein, p.G504Wfs*12, lacking the nuclear localization signal. The levels of FUS mRNA in the proband were not significantly different compared to controls. Western immunoblot analysis showed that one antibody (500-526) detected in the proband ~50% of the amount of FUS protein compared to controls, while 3 other antibodies (2-27, 400-450 and FUS C-terminal), which recognize both wild type and the mutated FUS, detected 60% to 75% of the amount of the protein. These findings indicate that p.G504Wfs*12 FUS is more prone to undergo post-translational modification respect to wild type FUS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Exones / Pérdida de Heterocigocidad / Proteína FUS de Unión a ARN / Estudios de Asociación Genética / Disfunción Cognitiva / Heterocigoto / Esclerosis Amiotrófica Lateral / Mutación Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Child / Female / Humans Idioma: En Revista: Neurobiol Aging Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Exones / Pérdida de Heterocigocidad / Proteína FUS de Unión a ARN / Estudios de Asociación Genética / Disfunción Cognitiva / Heterocigoto / Esclerosis Amiotrófica Lateral / Mutación Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Child / Female / Humans Idioma: En Revista: Neurobiol Aging Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA